What is Cagrilintide?
Cagrilintide is a long-acting amylin analog peptide that works by slowing gastric emptying, reducing appetite, and increasing feelings of fullness — making it highly effective for weight loss and appetite regulation. It mimics the effects of amylin, a hormone co-secreted with insulin after eating.
Cagrilintide is often researched in combination with GLP-1 agonists (such as Semaglutide or Tirzepatide), showing synergistic effects on weight loss, caloric intake reduction, and metabolic improvement.
Key Benefits:
- ✅ Powerful appetite suppressant
- ✅ Slows gastric emptying and prolongs satiety
- ✅ Enhances weight loss when stacked with Semaglutide or Tirzepatide
- ✅ May improve insulin sensitivity and glucose control
- ✅ Helps with portion control and reduced snacking
- ✅ Ideal for individuals who plateaued on GLP-1s alone
Who Should Use Cagrilintide?
Cagrilintide is best suited for individuals seeking advanced fat loss solutions, especially those already using or transitioning into GLP-1-based peptides. It’s excellent for clients with appetite control issues, metabolic syndrome, or resistant body fat.
Format: 5mg lyophilized peptide vial
Suggested Use: Research dosing often mirrors GLP-1 titration models: 0.1–0.3mg weekly, increasing slowly based on tolerance. Often injected subcutaneously alongside Semaglutide or Tirzepatide.
Storage: Store in refrigerator once reconstituted
Note: This product is intended for research purposes only
Reviews
There are no reviews yet.